RSC Advances
Paper
(OCMe2CH2N), 65.2 (OCMe2), 64.8 (OCH2), 58.0 (OCH2CH2N), glove box, and 5 mL of freshly distilled acetonitrile was added
57.8 (OCH2CH2N), 32.49 (OCMe2), 32.45 (OCMe2). 1H NMR via a syringe, resulting in a clear solution. The corresponding
(C6D6, ppm): d 3.59 (t, 8H, J ¼ 5.8 Hz, OCH2), 2.36 (s, 4H, aldehyde (2 mmol) and TMSCN (3.5 mmol) were added
OCMe2CH2N), 2.23 (t, 8H, J ¼ 5.8 Hz, OCH2CH2N), 1.34 (s, 6H, sequentially under nitrogen, and the reaction mixture was
OCMe2), 1.26 (s, 6H, OCMe2). 13C NMR (C6D6, ppm): d 69.0 stirred at room temperature. Aer 1 h, the solvent and excess
(OCMe2CH2N), 65.4 (OCMe2), 65.0 (OCMe2CH2N), 58.3 (OCH2- TMSCN were evaporated at reduced pressure on a Schlenk line
CH2N), 58.0 (OCH2CH2N), 32.8 (OCMe2), 31.9 (OCMe2). 27Al at 70 C, and then 10 mL of hexanes was added. The precipi-
ꢁ
NMR (CDCl3, ppm): d 5.08 (Dn1/2 ¼ 1978.9 Hz). EI-MS (% tated catalyst was ltered, and the crude product was puried by
intensity): m/z 402 (4.0%, M+), 387 (42%, M+ ꢀ Me), 372 (3.0%, column chromatography (5% ethyl acetate in hexane).
M+ ꢀ 2Me), 358 (20%, M+ ꢀ 3Me), 344 (100% M+ ꢀ 4Me). Anal.
calc. for C16H32Al2N2O6: C, 47.76; H, 8.02; N, 6.96. Found: C,
47.59; H, 8.21; N, 7.02.
X-ray structural determination for 1–3
The crystallographic measurements were performed at 296(2) K
for all complexes 1–3 using a Bruker APEX II diffractometer with
Synthesis of 2. In a manner analogous to that used in the
synthesis of 1, the desired product 2 was prepared as colorless
crystals from a solution of AlMe3 (1.0 mL of 2 M solution in
toluene, 2.0 mmol) and L2H3 (0.41 g, 2.0 mmol) in THF in
˚
Mo Ka (l ¼ 0.71073 A) radiation. Specimens of suitable quality
and size were selected, mounted, and centered in the X-ray
beam using a video camera. The structures were solved by
direct methods and rened by full-matrix least-squares
methods using the SHELXTL58 program package with aniso-
tropic thermal parameters for all non-hydrogen atoms, result-
ing in the X-ray crystallographic data of 1–3 in CIF formats
(CCDC 1494116–1494118). Final renement based on the
reections (I > 2s(I)) converged at R1 ¼ 0.0903, wR2 ¼ 0.2667,
and GOF ¼ 1.082 for 1, at R1 ¼ 0.0579, wR2 ¼ 0.1526, and GOF ¼
1.017 for 2, and at R1 ¼ 0.0513, wR2 ¼ 0.1350, and GOF ¼ 1.060
for 3. Further details are listed in Table 5.
1
a yield of 79% (0.36 g). H NMR (CDCl3, ppm): d 3.73 (m, 4H,
CH2N), 2.88 (m, 4H, OCH2), 2.79 (m, 10H, OCMe2CH2N), 1.46 (s,
6H, OCMe2), 1.35 (s, 6H, OCMe2), 1.17 (s, 6H, OCMe2), 1.12 (s,
6H, OCMe2). 13C NMR (CDCl3, ppm): d 71.7 (OCMe2CH2N), 68.9
(OCMe2), 68.0 (OCMe2), 67.6 (OCH2CH2N), 62.2 (OCH2CH2N),
58.4 (OCMe2CH2N), 32.2 (OCMe2), 31.8 (OCMe2) 29.9 (OCMe2),
29.5 (OCMe2). 1H NMR (C6D6, ppm): d 3.80 (m, 4H, CH2N), 2.47
(m, 4H, OCH2), 2.35 (m, 10H, OCMe2CH2N), 1.58 (s, 6H, OCMe2),
1.51 (s, 6H, OCMe2), 1.32 (d, J ¼ 4.4 Hz, 12H, OCMe2). 13C NMR
(C6D6, ppm): d 71.6 (OCMe2CH2N), 68.5 (OCMe2), 68.3 (OCMe2),
67.0 (OCH2CH2N), 62.3 (OCH2CH2N), 58.9 (OCMe2CH2N), 32.9
(OCMe2), 32.3 (OCMe2) 30.2 (OCMe2), 30.1 (OCMe2). 27Al NMR
(CDCl3, ppm): d 7.90 (Dn1/2 ¼ 2962.6 Hz). EI-MS (% intensity): m/
z 458 (3.0%, M+), 443 (50%, M+ ꢀ Me), 413 (0.99%, M+ ꢀ 2Me),
400 (100%, M+ ꢀ 3Me), 309 (20%, M+ ꢀ 4Me), 385 (19% M+ ꢀ
5Me), 370 (3.0% M+ ꢀ 6Me). Anal. calc. for C20H40Al2N2O6: C,
52.39; H, 8.79; N, 6.11. Found: C, 52.48; H, 8.91; N, 5.98.
Computational details for 1, 2 and their isomers
The geometry optimization for the ground-state (S0) structures
of 1, 2 and their isomers based on the X-ray structures of 1 and 2
were performed at the B3LYP/6-31+G(d) level of theory. Imagi-
nary frequencies for the optimized structures were not
observed. All the calculations were performed for gas-phase
molecules and were carried out using the Gaussian 09 so-
ware package.59 The dissociation energy barriers between Al and
bridged O atom of 1–3 could be calculated as the thermal
stabilities between before and aer dissociation of Al–O bonds
in gas phase.
Synthesis of 3. In a manner analogous to that used in the
procedure for 1, the desired product 3 as colorless crystals was
prepared from a solution of AlMe3 (1.0 mL of 2 M solution in
toluene, 2.0 mmol) and L3H3 (0.46 g, 2.0 mmol) in THF in
1
a yield of 67% (0.34 g). H NMR (CDCl3, ppm): d 2.79 (s, 4H,
CH2N), 2.78 (s, 4H, CH2N), 2.78 (s, 4H, CH2N), 1.41 (s, 12H,
OCMe2), 1.18 (s, 12H, OCMe2), 1.16 (s, 12H, OCMe2). 13C NMR
Conclusions
(CDCl3, ppm): d 72.8 (CH2N), 71.5 (OCMe2), 71.0 (CH2N), 68.4
1
(OCMe2), 32.2 (OCMe2), 31.9 (OCMe2), 29.1 (OCMe2). H NMR We designed and explored novel dimeric alumatranes with
(C6D6, ppm): d 2.484 (s, 4H, CH2N), 2.482 (s, 4H, CH2N), 2.37 (s, tricyclic ve-membered rings. The obtained alumatranes were
4H, CH2N), 1.54 (s, 12H, OCMe2), 1.38 (s, 12H, OCMe2), 1.34 (s, all dimeric in the solid state, solution phase, and the gas phase.
12H, OCMe2). 13C NMR (C6D6, ppm): d 72.7 (CH2N), 71.5 According to single-crystal X-ray analysis, the rst structurally
(OCMe2), 70.7 (CH2N), 68.7 (OCMe2), 32.6 (OCMe2), 32.3 characterized dimeric alumatranes abnormally had their steri-
(OCMe2), 29.5 (OCMe2). 27Al NMR (CDCl3, ppm): d 8.05 (Dn1/2
¼
cally bulky side arms with dimethyl substituents in the bridging
1874.7 Hz). EI-MS (% intensity): m/z 514 (6.00%, M+), 499 sites of the tetradentate ligand, which was also determined by
(63.00%, M+ ꢀ Me), 456 (100.0%, M+ ꢀ 4Me), 441 (44.00%, M+ ꢀ DFT calculations. The new alumatranes were used as catalysts
5Me), 426 (3.00% M+ ꢀ 6Me). Anal. calc. for C24H48Al2N2O6: C, for the trimethylsilylcyanation reaction of aldehydes under
56.01; H, 9.40; N, 5.44. Found: C, 56.22; H, 9.31; N, 5.50%.
extremely mild conditions of room temperature, less than
0.5 mol% catalyst loading, and a short reaction time of 1 h. The
new catalytic systems showed high catalytic activities regardless
of the aldehyde type, which included electron-rich, neutral, and
decient aryl aldehydes, heterocyclic aldehydes, and alkyl
Representative procedures for the trimethylsilylcyanation
reaction
In a glove box, a 10 mL vial was charged with 1–3 (0.01 mmol, aldehydes. Further explorations of the synthesis and applica-
0.5 mol% relative to aldehyde); the vial was removed from the tion of chiral alumatranes are in progress.
48158 | RSC Adv., 2017, 7, 48151–48160
This journal is © The Royal Society of Chemistry 2017